KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Tax Provisions: 2009-2024

Historic Tax Provisions for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to -$239,000.

  • Nektar Therapeutics' Tax Provisions fell 466.67% to -$33,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$428,000, marking a year-over-year decrease of 4655.56%. This contributed to the annual value of -$239,000 for FY2024, which is 19.50% down from last year.
  • Latest data reveals that Nektar Therapeutics reported Tax Provisions of -$239,000 as of FY2024, which was down 19.50% from -$200,000 recorded in FY2023.
  • Over the past 5 years, Nektar Therapeutics' Tax Provisions peaked at $3.2 million during FY2022, and registered a low of -$239,000 during FY2024.
  • Over the past 3 years, Nektar Therapeutics' median Tax Provisions value was -$200,000 (recorded in 2023), while the average stood at $925,333.
  • Its Tax Provisions has fluctuated over the past 5 years, first surged by 387.86% in 2022, then slumped by 106.22% in 2023.
  • Over the past 5 years, Nektar Therapeutics' Tax Provisions (Yearly) stood at $493,000 in 2020, then skyrocketed by 33.67% to $659,000 in 2021, then surged by 387.86% to $3.2 million in 2022, then tumbled by 106.22% to -$200,000 in 2023, then decreased by 19.50% to -$239,000 in 2024.